Effects of intravenous administration of pirfenidone on horses with experimentally induced endotoxemia
| Autor: | Ken J. Grattendick, Amy E Poulin Braim, Melinda H. MacDonald, M. L. Bruss, Solomon B. Margolin, Shri N. Giri |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Lipopolysaccharides
Male Analysis of Variance IV Infusion General Veterinary Pyridones Tumor Necrosis Factor-alpha business.industry medicine.medical_treatment Low dose General Medicine Pirfenidone Constant rate infusion Loading dose Endotoxemia Anesthesia Injections Intravenous medicine Animals Horse Diseases Horses business Saline medicine.drug |
| Zdroj: | American Journal of Veterinary Research. 70:1031-1042 |
| ISSN: | 0002-9645 |
| DOI: | 10.2460/ajvr.70.8.1031 |
| Popis: | Objective—To characterize effects of IV administration of pirfenidone on clinical, biochemical, and hematologic variables and circulating tumor necrosis factor (TNF)-α concentrations in horses after infusion of a low dose of endotoxin. Animals—18 healthy adult horses. Procedures—Horses were randomly assigned to 3 groups (n = 6 horses/group) and administered an IV infusion of 30 ng of endotoxin/kg or saline (0.9% NaCl) solution during a 30-minute period. Lipopolysaccharide-pirfenidone horses received endotoxin followed by pirfenidone (loading dose of 11.6 mg/kg and then constant rate infusion [CRI] at 9.9 mg/kg/h for 3 hours). Lipopolysaccharide-saline horses received endotoxin followed by infusion (loading dose and CRI for 3 hours) of saline solution. Saline-pirfenidone horses received saline solution followed by pirfenidone (loading dose and then CRI for 3 hours). Physical examination variables were recorded and blood samples collected at predetermined intervals throughout the 24-hour study period. Blood samples were used for CBCs, biochemical analyses, and determinations of TNF-α concentrations. Results—IV infusion of pirfenidone after administration of a low dose of endotoxin failed to attenuate the clinical, clinicopathologic, or cytokine alterations that developed secondary to endotoxin exposure. Intravenous infusion of pirfenidone after administration of saline solution induced mild transient clinical signs, but associated clinicopathologic changes were not detected. Conclusions and Clinical Relevance—IV administration of pirfenidone was tolerated with only mild transient clinical adverse effects during infusion. However, administration of pirfenidone did not protect horses from the systemic effects of experimentally induced endotoxemia. Further studies of related, but more potent, drugs may be warranted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|